Ercanetide (INNTooltip International Nonproprietary Name; developmental code name NNZ-2591) is a synthetic analog of cyclic glycine-proline (cGP) and experimental drug developed for Angelman syndrome, Phelan-McDermid syndrome, Pitt Hopkins syndrome, and Prader-Willi syndrome.
See also Traneurocin (NA-831)
References